Wakefield D - Search Results

1

Adalimumab for the treatment of refractory active and inactive non-infectious uveitis.

Lee JT, Yates WB, Rogers S, Wakefield D, McCluskey P, Lim LL. Lee JT, et al. Among authors: wakefield d. Br J Ophthalmol. 2018 Dec;102(12):1672-1678. doi: 10.1136/bjophthalmol-2017-311234. Epub 2018 Feb 19. Br J Ophthalmol. 2018. PMID: 29459430

2

Methotrexate therapy for ocular cicatricial pemphigoid.

McCluskey P, Chang JH, Singh R, Wakefield D. McCluskey P, et al. Among authors: wakefield d. Ophthalmology. 2004 Apr;111(4):796-801. doi: 10.1016/j.ophtha.2003.07.010. Ophthalmology. 2004. PMID: 15051215

3

The role of PAMPs and DAMPs in the pathogenesis of acute and recurrent anterior uveitis.

Wakefield D, Gray P, Chang J, Di Girolamo N, McCluskey P. Wakefield D, et al. Br J Ophthalmol. 2010 Mar;94(3):271-4. doi: 10.1136/bjo.2008.146753. Epub 2009 Mar 4. Br J Ophthalmol. 2010. PMID: 19264730 Review.

4

Outcomes of changing immunosuppressive therapy after treatment failure in patients with noninfectious uveitis.

Joshi L, Talat L, Yaganti S, Sandhu S, Taylor SR, Wakefield D, McCluskey P, Lightman S. Joshi L, et al. Among authors: wakefield d. Ophthalmology. 2014 May;121(5):1119-24. doi: 10.1016/j.ophtha.2013.11.032. Epub 2014 Jan 13. Ophthalmology. 2014. PMID: 24433970

5

Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.

Yates WB, Vajdic CM, Na R, McCluskey PJ, Wakefield D. Yates WB, et al. Among authors: wakefield d. Ophthalmology. 2015 Feb;122(2):265-73. doi: 10.1016/j.ophtha.2014.08.024. Epub 2014 Oct 11. Ophthalmology. 2015. PMID: 25312044

6

Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia-Clinical Features, Treatment, and Prognosis.

Yates WB, Chiong F, Zagora S, Post JJ, Wakefield D, McCluskey P. Yates WB, et al. Among authors: wakefield d. Asia Pac J Ophthalmol (Phila). 2019 Jul-Aug;8(4):280-284. doi: 10.1097/APO.0000000000000244. Asia Pac J Ophthalmol (Phila). 2019. PMID: 31369405 Free PMC article.

7

Prediction of response to treatment in patients with scleritis using a standardised scoring system.

McCluskey P, Wakefield D. McCluskey P, et al. Among authors: wakefield d. Aust N Z J Ophthalmol. 1991 Aug;19(3):211-5. doi: 10.1111/j.1442-9071.1991.tb00663.x. Aust N Z J Ophthalmol. 1991. PMID: 1958366

8

Cyclosporin therapy for severe scleritis.

Wakefield D, McCluskey P. Wakefield D, et al. Br J Ophthalmol. 1989 Sep;73(9):743-6. doi: 10.1136/bjo.73.9.743. Br J Ophthalmol. 1989. PMID: 2804030 Free PMC article.

9

Systemic immunosuppression in the treatment of posterior uveitis.

Wakefield D, McCluskey P. Wakefield D, et al. Int Ophthalmol Clin. 1995 Summer;35(3):107-22. doi: 10.1097/00004397-199503530-00009. Int Ophthalmol Clin. 1995. PMID: 8964661 Review. No abstract available.

10

Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis.

Wakefield D, Jennings A, McCluskey PJ. Wakefield D, et al. Clin Exp Ophthalmol. 2000 Apr;28(2):103-6. doi: 10.1046/j.1442-9071.2000.00282.x. Clin Exp Ophthalmol. 2000. PMID: 10933772 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

649 results

Search Page

Filters